Roswell Park Comprehensive Cancer Center has appointed Agnes Witkiewicz, MD, as Director of Cancer Genetics and Genomics. She will also hold the John & Santa Palisano Endowed Chair of Cancer Genetics.
An internationally recognized clinician-scientist who combines groundbreaking laboratory research with precision medicine, Dr. Witkiewicz joined Roswell Park in 2018. Her research interests include identifying molecular abnormalities and applying effective therapies to improve outcomes and quality of life for patients with cancer. She will also Co-Lead the Cancer Center Support Grant Genetics and Genomics Program.
Agnes Witkiewicz, MD
Genetics and Genomics
Genetics and genomics are extraordinarily important when it comes to changes that drive or predict cancer initiation or progression. Scientists at Roswell Park look at both to improve the understanding of what gives rise to cancer, to identify targeted therapies, and to provide biomarkers in individual patients with cancer.
“Dr. Witkiewicz’s expertise in molecular biology, genetics, and therapeutics helps guide and shape our clinical trials in ways that benefit our patients and greater research efforts immensely,” said Candace S. Johnson, PhD, President and Chief Executive Officer and M&T Presidential Chair in Leadership at Roswell Park. “We look forward to watching our programs related to cancer genetics reach new heights under her direction.”
Dr. Witkiewicz is a board-certified pathologist with a subspecialty in dermatopathology. Her medical degree is from Wroclaw University and Medical School in Poland, and she completed residencies at Beth Israel Deaconess Medical Center/Harvard Medical School and UMass Memorial Medical Center.
